Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION

Last updated on 2024-09-14 History
Report ID 235137
Drug Identification Number 02362635
Brand name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Common or Proper name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) TAZOBACTAM PIPERACILLIN
Strength(s) 0.5G 4.0G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10 X 4.5 G VIALS
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2024-08-09
Estimated end date
Actual end date 2024-09-13
Shortage status Resolved
Updated date 2024-09-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2024-09-14 English Compare
v4 2024-09-13 French Compare
v3 2024-09-13 English Compare
v2 2024-08-12 French Compare
v1 2024-08-12 English Compare

Showing 1 to 5 of 5